Oncolytic viruses in melanoma
Malignant melanoma recurrence remains heterogeneous in presentation, ranging from locoregional disease (i.e., local recurrence, satellites, in transit disease) to distant dermal and visceral metastases. This diverse spectrum of disease requires a personalized approach to management and has resulted...
Main Authors: | Camille Robinson, Maria M Xu, Smita K Nair, Georgia M Beasley, Kristen E Rhodin |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-02-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/2/10.31083/j.fbl2702063 |
Similar Items
-
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
by: Janine Kimpel, et al.
Published: (2018-03-01) -
Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines
by: Andra Tilgase, et al.
Published: (2020-04-01) -
Adrenal Gland and Gastric Malignant Melanoma without Evidence of Skin Lesion Treated with the Oncolytic Virus Rigvir
by: Guna Proboka, et al.
Published: (2020-04-01) -
Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma
by: Praveen K. Bommareddy, et al.
Published: (2019-07-01) -
Myxoma Virus-Loaded Mesenchymal Stem Cells in Experimental Oncolytic Therapy of Murine Pulmonary Melanoma
by: Joanna Jazowiecka-Rakus, et al.
Published: (2020-09-01)